Inventor · disambiguated record
Adam W. Sledeski
Also filed as: SLEDESKI ADAM W
9 granted patents·6 pending applications·96 citations·filing 1999–2013
87Inventor score
Files withAVENTIS PHARMA INC4AVENTIS PHARM PROD INC3CHOI-SLEDESKI YONG MI2SANOFI AVENTIS DEUTSCHLAND2AVENTIS PHARMA SA1
Top patents by PatentIndex Score
15 records- 0183US8497379B2Method and intermediates for the preparation of 2,2,2-trifluoro-N-(4-fluoro-3-pyridin-4-yl-benzyl)-acetamide hydrochlorideCHOI-SLEDESKI YONG MI·Filed 2012·Granted Jul 30, 2013·7 cites·4 claims
- 0282US6569993B1Process for the preparation of resin-bound cyclic peptidesAVENTIS PHARMA SA·Filed 1999·Granted May 27, 2003·45 cites·7 claims
- 0376US6429315B1Process for preparing N6-substituted adenosine derivativesAVENTIS PHARMA INC·Filed 2000·Granted Aug 6, 2002·16 cites·18 claims
- 0470US6753409B1STABLE NON-HYGROSCOPIC CRYSTALLINE FORM OF N-[N-[N-(4-(PIPERIDIN-4-YL)BUTANOYL)-N-ETHYLGLYCYL]ASPARTYL]-L-β-CYCLOHEXYL ALANINE AMIDE, INTERMEDIATES THEREOF, AND PREPARATION THEREOF AND OF ANTITHROMBOTIC AZACYCLOALKYLALKANOYL PEPTIDES AND PSEUDOPEPTIDESAVENTIS PHARMA INC·Filed 2000·Granted Jun 22, 2004·5 cites·17 claims
- 0568US8217178B2[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-flouro-1-(2-methoxy-ethyl)-4-trifluorom as an inhibitor of mast cell tryptaseCHOI-SLEDESKI YONG MI·Filed 2011·Granted Jul 10, 2012·1 cites·9 claims
- 0667US6153588AStable non-hygroscopic crystalline form of N-[N-[N-4-(piperidin-4-yl)butanoyl)-N-ethylglycyl] aspartyl]-L-β-cyclohexyl alanine amideAVENTIS PHARM PROD INC·Filed 1999·Granted Nov 28, 2000·17 cites·7 claims
- 0763US6184382B1Process for preparing N6-substituted adenosine derivativesAVENTIS PHARM PROD INC·Filed 2000·Granted Feb 6, 2001·3 cites·18 claims
- 0858US6180759B1Process for the preparation of azacycloalkylakanoyl pseudotetrapeptidesAVENTIS PHARM PROD INC·Filed 2000·Granted Jan 30, 2001·2 cites·57 claims
- 0948US2007197597A1Process for the preparation of tryptase inhibitorsSANOFI AVENTIS US LLC·Filed 2006·Application pending·0 cites
- 1046US8633321B2Synthesis of (4-fluoro-3-piperidin-4-yl-benzyl)-carbamic acid tert-butyl ester and intermediates thereofCHOY NAKYEN·Filed 2012·Granted Jan 21, 2014·0 cites·31 claims
- 1144US2007142435A1[4-(5-Aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptaseAVENTIS PHARMA INC·Filed 2006·Application pending·0 cites
- 1243US2004192734A14-(3-aminomethylphenyl)piperidin-1-yl]-[5-(2-fluorophenylethynyl)furan-2-yl]-methanone as an inhibitor of mast cell tryptaseAVENTIS PHARMA INC·Filed 2003·Application pending·0 cites
- 1342US2011015400A1Process for the preparation of tryptase inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2010·Application pending·0 cites
- 1436US2013225825A1Process for the preparation of tryptase inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2013·Application pending·0 cites
- 1533US2003069423A1Novel processes for the preparation of adenosine compounds and intermediates theretoFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adam W. Sledeski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →